SMAD2 and breast cancer: We observed that ENG suppression by shRNA in myCAFs not only attenuated TGF‐β‐Smad2/3 signaling and TGF‐β1 production but also inhibited the ability of these fibroblasts to promote tumor growth when co‐injected with human breast cancer cells subcutaneously into recipient mice.